These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 21549695)
1. Involvement of NCAM and FGF receptor signaling in the development of analgesic tolerance to morphine. Fujita-Hamabe W; Nakamoto K; Tokuyama S Eur J Pharmacol; 2011 Dec; 672(1-3):77-82. PubMed ID: 21549695 [TBL] [Abstract][Full Text] [Related]
2. Involvement of kappa opioid receptors in the formalin-induced inhibition of analgesic tolerance to morphine via suppression of conventional protein kinase C activation. Fujita-Hamabe W; Nagae R; Nawa A; Harada S; Nakamoto K; Tokuyama S J Pharm Pharmacol; 2010 Aug; 62(8):995-1002. PubMed ID: 20663033 [TBL] [Abstract][Full Text] [Related]
3. Involvement of kappa opioid receptors in the inhibition of receptor desensitization and PKC activation induced by repeated morphine treatment. Hamabe W; Yamane H; Harada S; Tokuyama S J Pharm Pharmacol; 2008 Sep; 60(9):1183-8. PubMed ID: 18718122 [TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotide knockdown of mGlu₅ receptor attenuates the antinociceptive tolerance and up-regulated expression of spinal protein kinase C associated with chronic morphine treatment. Xu T; Chen M; Zhou Q; Xue Y; Wang L; Bil De Arce VJ; Zhang X; Jiang W Eur J Pharmacol; 2012 May; 683(1-3):78-85. PubMed ID: 22429573 [TBL] [Abstract][Full Text] [Related]
6. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids. Kest B; McLemore G; Kao B; Inturrisi CE J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000 [TBL] [Abstract][Full Text] [Related]
7. Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice. Tokuyama S; Nagae R; Mashida E; Hamabe W J Pharm Pharmacol; 2007 Aug; 59(8):1109-15. PubMed ID: 17725853 [TBL] [Abstract][Full Text] [Related]
8. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors. Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677 [TBL] [Abstract][Full Text] [Related]
9. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice. Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235 [TBL] [Abstract][Full Text] [Related]
10. The involvement of midbrain astrocyte in the development of morphine tolerance. Harada S; Nakamoto K; Tokuyama S Life Sci; 2013 Oct; 93(16):573-8. PubMed ID: 23988850 [TBL] [Abstract][Full Text] [Related]
11. Involvement of the protein kinase Cgamma isoform in development of tolerance to nitrous oxide-induced antinociception in mice. Matsushita Y; Ishikawa M; Abe K; Utsunomiya I; Chikuma T; Hojo H; Hoshi K; Quock RM; Taguchi K Neuroscience; 2007 Aug; 148(2):541-7. PubMed ID: 17681696 [TBL] [Abstract][Full Text] [Related]
12. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain. Sánchez-Blázquez P; Rodríguez-Muñoz M; Berrocoso E; Garzón J Eur J Pharmacol; 2013 Sep; 716(1-3):94-105. PubMed ID: 23499699 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands. Boronat MA; Olmos G; García-Sevilla JA Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358 [TBL] [Abstract][Full Text] [Related]
16. Lack of tolerance and morphine-induced cross-tolerance to the analgesia of chimeric peptide of Met-enkephalin and FMRFa. Gupta K; Vats ID; Gupta YK; Saleem K; Pasha S Peptides; 2008 Dec; 29(12):2266-75. PubMed ID: 18930087 [TBL] [Abstract][Full Text] [Related]
17. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II. Tang L; Shukla PK; Wang LX; Wang ZJ J Pharmacol Exp Ther; 2006 May; 317(2):901-9. PubMed ID: 16505162 [TBL] [Abstract][Full Text] [Related]
18. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling. Wang HY; Friedman E; Olmstead MC; Burns LH Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657 [TBL] [Abstract][Full Text] [Related]
19. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice. Bhalla S; Zhang Z; Patterson N; Gulati A Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944 [TBL] [Abstract][Full Text] [Related]
20. Changes in G proteins genes expression in rat lumbar spinal cord support the inhibitory effect of chronic pain on the development of tolerance to morphine analgesia. Javan M; Ahmadiani A; Motamadi F; Kazemi B Neurosci Res; 2005 Nov; 53(3):250-6. PubMed ID: 16055216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]